Histogen Inc reports results for the quarter ended in December - Earnings Summary

Histogen

09/03/2023 22:36

* Histogen Inc  HSTO.OQ  reported a quarterly adjusted loss
of 61
cents​​ per share for the quarter ended in December. The mean
expectation of two analysts for the quarter was for a loss of 79
cents per share.
    * Revenue fell 20% to $4.00 thousand from a year ago;
analysts
expected $352.50 thousand. 
    * Histogen Inc's reported EPS for the quarter was a loss
of 61
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Histogen Inc shares had risen by 28.9% this quarter.
    * The company reported a quarterly loss of $2.96 million.
    * Wall Street's median 12-month price target for Histogen
Inc is
$5.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 9 at 10:36 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.79          -0.61          Beat
 Sep. 30 2022      -1.26          -1.01          Beat
 Jun. 30 2022      -1.70          -1.55          Beat
 Mar. 31 2022      -1.50          -0.20          Beat